<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">4695</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"> https://doi.org/10.31782/IJCRR.2021.SP288</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>&#13;
	Pleomorphic Adenoma: A Case Report&#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
&#13;
&#13;
	 &#13;
&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhor</surname><given-names>Ketaki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Tamgadge</surname><given-names>Avinash</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pereira</surname><given-names>Treville</given-names></name></contrib><contrib contrib-type="author"><name><surname>Manishankar</surname><given-names>Suraj</given-names></name></contrib><contrib contrib-type="author"><name><surname>Kathe</surname><given-names>Atharva Anil</given-names></name></contrib><contrib contrib-type="author"><name><surname>Suryanarayan</surname><given-names>Mahek</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>26</day><month>05</month><year>2021</year></pub-date><volume>ar</volume><issue>me</issue><fpage>201</fpage><lpage>203</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>&#13;
	Introduction: Pleomorphic adenoma is a benign salivary gland tumour that most commonly originates in the parotid gland, mainly involving the superficial lobe. Pleomorphic adenoma is a painless growth that grows in size over time if left untreated. It is more common in women and occurs between the ages of 30 and 60. Surgical excision exposes the facial nerve to injury as it penetrates the substance of the parotid gland and separates into terminal branches. Case Report: We discuss a case of a pleomorphic adenoma of the right parotid gland presented by a 35-year-old lady and handled by surgical excision, as well as details of the critical structures encountered. Conclusion: Despite being a benign tumor of the salivary gland, pleomorphic adenoma should be detected early, and complete local surgical excision with negative microscopic margins is advised. Whenever possible, care should be taken to protect the facial nerve when dealing with the parotid gland. For preventing recurrence and malignant transformation, care must be made to completely eradicate the lesion.&#13;
&#13;
</p></abstract><kwd-group><kwd>Pleomorphic Adenoma</kwd><kwd> Salivary Gland Tumor</kwd><kwd> Parotid Gland</kwd><kwd> Facial Nerve</kwd><kwd> Benign Tumor</kwd></kwd-group></article-meta></front></article>
